VCYT

36.45

1.03% 0.37

Handel nachbörslich: 36.45

Veracyte Inc (VCYT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$36.08

Offen:

$35.97

24-Stunden-Volumen:

705.45K

Relative Volume:

0.70

Marktkapitalisierung:

$2.87B

Einnahmen:

$399.58M

Nettoeinkommen (Verlust:

$-54.04M

KGV:

-48.60

EPS:

-0.75

Netto-Cashflow:

$40.13M

1W Leistung:

+1.33%

1M Leistung:

+1.25%

6M Leistung:

+20.10%

1J Leistung:

+6.24%

1-Tages-Spanne:

$35.30

$36.55

1-Wochen-Bereich:

$34.84

$36.55

52-Wochen-Spanne:

$22.61

$47.32

Veracyte Inc Stock (VCYT) Company Profile

Firmenname

Veracyte Inc

Sektor

Healthcare (1136)

Branche

Diagnostics & Research (53)

Telefon

(650) 243-6300

Adresse

6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA

Mitarbeiter

824

Twitter

@veracyte

Nächster Verdiensttermin

2025-02-24

Neueste SEC-Einreichungen

VCYT's Discussions on Twitter

Vergleichen Sie VCYT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VCYT Veracyte Inc	36.45	2.84B	399.58M	-54.04M	40.13M	-0.75
TMO Thermo Fisher Scientific Inc	564.88	213.17B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	214.06	152.13B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	722.94	50.36B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	144.69	41.49B	6.79B	1.22B	1.09B	4.2644
IQV Iqvia Holdings Inc	213.88	36.86B	15.90B	1.28B	2.21B	7.2842

Veracyte Inc Stock (VCYT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-20	Eingeleitet	Canaccord Genuity	Hold
2025-03-20	Eingeleitet	Craig Hallum	Buy
2024-12-05	Herabstufung	Goldman	Buy → Neutral
2024-11-15	Eingeleitet	Wolfe Research	Outperform
2024-10-16	Eingeleitet	UBS	Buy
2024-10-10	Eingeleitet	Guggenheim	Buy
2024-02-23	Bestätigt	Needham	Buy
2023-01-18	Herabstufung	Raymond James	Outperform → Mkt Perform
2023-01-05	Eingeleitet	Scotiabank	Sector Outperform
2022-01-07	Eingeleitet	Stephens	Overweight
2021-11-18	Fortgesetzt	Goldman	Buy
2021-06-15	Eingeleitet	Raymond James	Outperform
2021-02-18	Fortgesetzt	Needham	Buy
2021-01-28	Eingeleitet	Truist	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-09	Eingeleitet	Morgan Stanley	Underweight
2019-07-31	Eingeleitet	Lake Street	Buy
2019-07-02	Eingeleitet	Needham	Buy
2018-11-29	Herabstufung	Janney	Buy → Neutral
2018-10-31	Hochstufung	Janney	Neutral → Buy
2017-11-07	Herabstufung	Janney	Buy → Neutral
2017-11-07	Herabstufung	Piper Jaffray	Overweight → Neutral
2017-08-31	Fortgesetzt	BTIG Research	Buy
2016-11-14	Fortgesetzt	Leerink Partners	Outperform
2015-12-18	Eingeleitet	Cantor Fitzgerald	Buy
2015-06-11	Bestätigt	Leerink Partners	Outperform
2013-11-26	Eingeleitet	William Blair	Outperform

Alle ansehen

Veracyte Inc Aktie (VCYT) Neueste Nachrichten

06:14 AM

Veracyte (VCYT) Studies Highlight Afirma GRID's Role in Thyroid Cancer Research - GuruFocus

06:14 AM

04:15 AM

Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing - Business Wire

04:15 AM

10:05 AM

Chart based analysis of Veracyte Inc. trendsJuly 2025 Weekly Recap & Low Risk Investment Opportunities - newser.com

10:05 AM

09:45 AM

Can Veracyte Inc. stock beat market expectations this quarter2025 Biggest Moves & Short-Term Trading Opportunity Alerts - newser.com

09:45 AM

08:31 AM

Heatmap analysis for Veracyte Inc. and competitors2025 Trading Volume Trends & Comprehensive Market Scan Insights - newser.com

08:31 AM

07:55 AM

Wakefield Asset Management LLLP Buys New Holdings in Veracyte, Inc. $VCYT - MarketBeat

07:55 AM

07:31 AM

What To Expect From Veracyte Inc (VCYT) Q3 2025 Earnings - Yahoo Finance

07:31 AM

06:39 AM

Can swing trading help recover from Veracyte Inc. lossesJuly 2025 Setups & Weekly Breakout Stock Alerts - newser.com

06:39 AM

05:14 AM

What to do if you’re stuck in Veracyte Inc.2025 Top Decliners & Community Verified Trade Alerts - newser.com

05:14 AM

03:20 AM